redditalpha logoredditalpha
← 返回看板
分享
2100%
r/valueinvestingr/valueinvesting· u/ComprehensiveOven341· 6 天前Discussion 7

过去几周建仓了这些标的

投资者摘要看多

作者详细分享了建仓 ADBE、CRM、NOW、SAP、RELX、WKL、PEGA、MSFT、PYPL、NKE、ADYEN、NVO 和 ABT 的价值投资逻辑。

看多要点
  • 多家高质量公司交易估值具有吸引力或低于历史倍数。
  • 企业软件中的 AI 整合正推动实际收入增长并降低流失率,而非造成颠覆。
  • 强大的竞争护城河、定价权和嵌入式工作流提供了下行保护和长期稳定性。
ADBECRMSAPRELXWKLPEGAMSFTPYPLGLP-1 减肥药价值 / 回购
帖子正文
高质量模型翻译结果

过去几周一直在不同板块悄悄建仓。

ADBE:认为AI会摧毁Adobe的说法忽视了一个事实,即Adobe正积极将AI整合进其产品中。目前该股交易价格低于历史估值倍数,同时AI收入增长强劲,这看起来更像是暂时的市场错配。

CRM:Agentforce尚处早期,但确有实效。Salesforce拥有企业关系网络和分销渠道,足以让AI代理真正落地。

NOW:ServiceNow具备定价权,企业合同粘性强,且AI整合反而降低了客户流失率,而非带来风险。

SAP:虽然不如美国同行受关注,但业务转型真实存在,估值也更为宽容。

RELX:客户很难轻易离开这些平台。高盛最近将其加入买入名单,公司也启动了股票回购计划。

WKL:与RELX类似。深度嵌入会计、法律和合规工作流程中。

PEGA:在我看来,股价远低于内在价值。

MSFT:从第一天起就是我最青睐的持股。看到当前价位真是令人欣喜。

PYPL:品牌化结账功能趋于稳定,利润率改善,而你只需支付一个极低的倍数,就能获得一个拥有超过4亿活跃账户的网络。

NKE:我知道耐克确实曾面临执行问题,但品牌基本面依然稳固,新任CEO在直营渠道方面正采取正确的举措。

ADYEN:欧洲最优质的金融科技企业之一。交易量增长已重回正轨,长期在企业支付领域的布局依然坚如磐石。

NVO:是的,GLP-1的竞争确实存在,估值也相应调整。但诺和诺德的研发管线、制造规模优势以及在肥胖症/糖尿病领域的品牌影响力,使其风险收益特征与市场定价完全不同。

ABT:一家稳健且多元化的医疗健康企业,却常被忽视。

我很想知道大家对这些选股的看法,尤其想听听对软件公司面临AI颠覆的反驳意见。

讨论 · 高赞评论9 条精选
u/Full-Comfortable8074 8· 6 天前

How much are you down ytd?

u/WarmFaithlessness946 1· 6 天前

Everthing below 50% is a win i guess

u/Full-Comfortable8074 1· 6 天前

Yeah its crazy i own wkl Adyen and now aswell the only thing keeping my ytd up is the ia trade lol

u/ComprehensiveOven341 2· 6 天前

Haha, yeah, same for me. Overall I’m up YTD thanks to all the AI picks and Big Data and AI focused ETFs

u/Bilbo_Butthole 3· 6 天前

Bagholders Anonmyous should be the name of this sub lol

u/theunknown996 2· 6 天前

I highly doubt you have a deep understanding of every company you bought. Who has time to follow and research all of them? Many hedge funds don't even have as many positions and you have over a dozen that only accounts for small portion of your portfolio.

Seriously what's the point?

u/Invest0rnoob1 2· 6 天前

Why buy stocks that are going up, when you can buy stuff that keeps going down!

u/ninjagorilla 1· 6 天前

That’s 13 companies….. you seriously couldn’t pick between those 13? There have to be one or 2 that have better numbers or you like better. 13 is a full portfolio, there’s no way you like them equally. And if it is your whole portfolio then it’s horribly diversified .

Of the list there are about 3-4 I don’t know about, 2 I like (Abbt and now) 3 I’ve looked at and I wouldn’t touch (nke, pypl, nvo )…. And the rest are “fine” at best

Look it’s your money and I may be completely wrong, so do what you think is best, but that feels like a real ugly portfolio

u/ComprehensiveOven341 1· 6 天前

I get your point, though I’m not really giving any context about my portfolio allocation. The vast majority (\~80%) of my money is in ETFs/index funds. But I also like buying individual stocks when I think the market is wrong. So the stocks mentioned in this post are part of that portion of my portfolio, among others ofcourse.